Effect of lipid-lowering therapy by statin on progression of chronic kidney disease with diabetes

Therapeutic Research

Volumn 31, Issue 9, 2010, Pages 1242-1243

  Bando, Yukihiro ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

STATIN;

CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFECT;

EID: 78049346535     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the collaborative atorvastatin diabetes study (CARDS). Am J Kidney Dis 2009;54:810-9.
2. Shepherd J, Kastelein JJP, Bittner V, Deedwania P, Breazna A, Dobson S, et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol 2007;2:1131-9.
3. Athyros VG, Mikhailidis DP, Papageorgiou AA, Mercouris BR, Elisaf M, Koren MJ, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 2004;57:728-34. (Pubitemid 38901488)